Han Ding Yuyou will turn from profit to loss in 2019, and its subsidiaries will have a false increase in business

Han Ding Yuyou will turn from profit to loss in 2019, and its subsidiaries will have a false increase in business

Han Ding Yuyou will turn from profit to loss in 2019, and its subsidiaries will have a false increase in business
Subsidiaries have increased their business, and Han Ding Yuyou has made many adjustments in its 2019 annual report.On April 30, Han Ding Yuyou’s financial report showed that it will achieve operating income in 20194.5.2 billion, a decrease of 14.43%.However, Han Ding Yuyou turned from profit to loss in 2019 with a net profit of -7.9.3 billion yuan, compared with the adjusted net profit of the previous year.2.4 billion, down 738.17%.Due to the false increase in business of the subsidiary Good Medical Friends, Han Ding Yuyou adjusted the net profit and other data for the first three quarters after self-examination.  Information shows that Han Ding Yuyou currently has two core businesses of smart city and finance, smart medical and business, and has invested in companies including micro-loan, aurora big data, bee assistant, Xu Nuo Pharmaceutical and other companies. Summary of the report, Hannuo Yuyou’s shareholding subsidiary Xu Nuo Pharmaceutical (stock code: XYN) was listed on the Nasdaq Stock Exchange, and the shareholding subsidiary Bee Assistant entered the listing counseling period.  In the financial report, Han Ding Yuyou announced a correction of accounting errors.In 2018, Han Ding Yuyou acquired Haoyiyou Medical Technology Group Co., Ltd., referred to as its holding subsidiary, and began to merge and merge in June 2018, with a shareholding ratio of 40%.  In 2019, Han Ding Yuyou conducted a self-examination of the income, cost confirmation, and expenses of Haoyiyou during the consolidated statement, and found that in this report, it inflated business and inflated revenue, costs and other matters.Han Ding Yuyou adjusted the financial data on this matter, involving revenue and net profit for the first three quarters.Among them, the net profit attributable to shareholders of listed companies in the first quarter was reduced by 104.860,000 yuan, net profit attributable to shareholders of listed companies increased by 79 in the second quarter.330,000 yuan, net profit attributable to shareholders of listed companies decreased by 137 in the third quarter.490,000 yuan.  In addition, Han Ding Yuyou revealed that the good medical friend in 2018 increased the main business income through the remote medical service business by 7533.690,000 yuan, the main business cost 3923.730,000 yuan and the period cost 3388.410,000 yuan, affecting the net profit attributable to shareholders of the parent company -34 in 2018.180 thousand yuan.Before the correction, the net profit achieved by good doctors in June-December 2018 was -1349.940,000 yuan.  While disclosing the 2019 financial report, Han Ding Yuyou also released its first quarter report for 2020.The data shows that during the period of Han Dingyu You revenue, net profit every two intervals.24% and 141.94%.  Regarding the reasons for driving changes in business income, Han Ding Yuyou explained that the report was affected by the macro environment and the company’s business income declined year-on-year.Among them, the progress of the construction projects of the smart city business, the tendering of new projects, and the delay in the delivery and settlement of completed projects have caused the company’s new projects and confirmed revenue to decline significantly.The theater segment to which the company belongs has ceased business since January 23, 2020, and has not resumed work at the end of the reporting period, resulting in a substantial decline in its operating income compared with the same period last year.Reporter Chen Peng editor Sun Yong proofreading Li Ming